As part of Dutch Bio Science Week 2025, TechTalkXL brought together the Cell and Gene Therapy community for an afternoon of focused exchange at Mirai House. Organised by NecstGen in collaboration with Leiden Bio Science Park, the event provided a setting to examine both therapeutic development and the practical realities of producing advanced therapies.
Speakers and guests represented a wide range of perspectives from academia, biotech, and early-stage ventures. Discussions covered topics such as gene editing, T-cell engineering, NK cell applications, decentralised manufacturing, data handling, donor safety, and the infrastructure required to support these therapies.
The main programme featured presentations from Frank Staal of LUMC on clinical developments in gene therapy for rare genetic diseases, Ester Weijers of NTrans on a non-viral CRISPR delivery platform, Anna-Maria Georgoudaki of Glycostem on off-the-shelf NK cell therapies, and Gemma Parsons of Galapagos on a decentralised, digitally enabled model for fresh cell therapy manufacturing.
In the snapshot session, shorter talks focused on advances in manufacturing. Topics included modular automation, decentralised production models, advanced sterility testing, closing the process, and data-informed quality systems. Presenters brought insight from KU Leuven, Fraunhofer IPT, Biotactical, WMDA, and NecstGen.
Events like these are part of our broader effort to strengthen collaboration across the Cell and Gene Therapy development chain. The aim is to help bring advanced therapies to patients with greater consistency, confidence, and speed.
We thank all speakers for their contributions and all attendees for making time in a busy week to take part in these conversations.
On September 24, NecstGen will host the next CGT Circle session at Mirai House. Details on the programme and registration will follow shortly. For now, we invite you to save the date.
Photos below capture a few moments from the afternoon. We look forward to welcoming you again.
